Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Société Clinical Skincare Comes to Skin’s Rescue with New Calming Relief Balm
  • USA - English


News provided by

Societe Skincare

Nov 12, 2013, 14:20 ET

Share this article

Share toX

Share this article

Share toX

Societe Clinical Skincare's Calming Relief Balm stops the inflammation cascade to calm and soothe irritated and post-procedure skin.
Societe Clinical Skincare's Calming Relief Balm stops the inflammation cascade to calm and soothe irritated and post-procedure skin.

Atlanta, GA (PRWEB) November 12, 2013 -- Inflammatory skin conditions affect more than 35 million Americans who, in turn, spend more than $2 billion a year to treat their symptoms. Skin inflammation can be characterized as acute or chronic, and the long-term effects of chronic inflammation can cause significant and serious tissue damage. Société Clinical Skincare comes to skin’s rescue with a new Calming Relief Balm (CRB), which contains ingredients to help reduce inflammation, soothe irritated skin, and reduce dryness and flakiness, to stop inflammation in its tracks and repair damaged skin.

“In my 25 years in the skin care industry, this product is the absolute best on the market for calming redness and skin irritation on my patients,” said Denise Byrnes, product development officer and co-founder of Société Clinical Skincare.

Post this

Similar to a first-aid cream, CRB provides the same healing benefits as hydrocortisone, without the use of hydrocortisone, which thins the skin with long-term usage. CRB contains active ingredients known for their moisturizing, anti-inflammatory, immunomodulatory and anti-oxidant effects, including: Aloe; Shea Butter; Soybean Oil; Borage Oil; and, a multi-herbal complex extracted from seven plants – Rosemary, Chamomile, Green Tea, Licorice, Japanese Knotweed, Skullcap and Gotu Kola.

The most revolutionary of its ingredients is Sea Whip Extract, one of the most effective anti-inflammatories on the market. A natural ingredient that is safe, effective and environmentally friendly, Sea Whip is a marine organism found in the Caribbean Sea, and is a renewable resource harvested off the plant itself in the form of polyps, which only occur a few times each year.

“In my 25 years in the skin care industry, this product is the absolute best on the market for calming redness and skin irritation on my patients,” said Denise Byrnes, product development officer and co-founder of Société Clinical Skincare. “Historically, the approach has been to use hydrocortisone and heavy petroleum to suffocate and stop inflammation, but this can thin and damage skin over time. We have intentionally avoided these ingredients, and have taken a new approach to treating and healing skin by stopping the inflammation cascade before it begins.”

CRB treats a variety of skin conditions that can occur at any stage of life, including acne, rosacea/hypersensitivity, sunburn/windburn, chapping and extreme dryness. It is extremely beneficial in aiding post laser, post peel, and post op skin recovery, helping to reduce redness and itching, and calm irritation.

“Everyone should keep CRB on-hand for unexpected and chronic skin inflammation,” continued Byrnes. “Especially with the holiday season quickly approaching – think party planning stress, rich food and increased alcohol intake. This product stops inflammation and irritation in its tracks, so you can focus on the holidays and not on inflammatory skin conditions.”

Another product bonus is the non-greasy delivery system. Developed using the newest technology available, CRB absorbs quickly into the skin without leaving a greasy residue. It delivers moisture deep into the skin to help restore skin’s elasticity, yet it creates a protective barrier on the skin’s surface, leaving skin smoother and clearer.

For best results, apply CRB to the affected area 3-4 times daily, or as directed by your medical professional. For sensitive, reddened and rosacea skin types, apply to the affected area twice daily – in the morning and at night.

Developed and tested in a clinical setting, Société’s unique formulations contain high performance, patent-pending ingredients and are paraben free, propylene glycol free and sodium lauryl sulfate free – and further-reinforce the nexus between science and skincare.

Société is available only through a physician’s office and uses a customized approach to treating a variety of skin types, including hyperpigmentation, acne-prone, hypersensitive and aging skin. This delivery system puts the professional in control of patient results, removing the ‘self treatment/self diagnosis’ that oftentimes reaps lackluster results. Visit http://www.Societeskincare.com to view the full line of Société’s products and peels.

About Société Clinical Skincare, LLC
Founded in Atlanta, GA in 2008, Société Clinical Skincare’s exclusive products are created with the professional skin care specialist in mind. Developed and tested in a clinical setting, the innovative formulations contain high performance, patent-pending ingredients that are free of parabens, propylene glycol and sodium lauryl sulfate. The Société Transition Peel System is a customized approach for treating a variety of skin types, putting the skin care professional back in control of patient results. Sold solely through the physician community the Société line is easy to prescribe and designed to increase overall patient satisfaction while maximizing clinic profits.

Société products are distributed domestically in the United States, and internationally in five countries, with additional distribution and product line expansion planned throughout 2013.

One of Société’s core priorities is its environmental impact, which is taken into account throughout all facets of the business, including: recyclable product packaging, eco-friendly ingredients, recycling, paperless systems and renewable energy. Société products are cruelty-free and never tested on animals. For more information, visit http://www.Societeskincare.com or http://www.facebook.com/Societeskincare.

Media contact:
Cheryl Monkhouse, Global Public Relations Director
404.822.2036
cheryl(at)Societeskincare(dot)com

Cheryl Monkhouse, Societe Skincare, http://www.societeskincare.com, 404-822-2036, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.